This is a follow-up protocol providing long-term monitoring for people who previously took part in a gene therapy study at the NCI Center for Immuno-Oncology. It enrolls, by invitation, people aged 18 and older who were enrolled in an applicable NCI gene therapy treatment protocol. It is a study without an assigned phase and enrolls by invitation.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
* INCLUSION CRITERIA: * Subjects who have enrolled on an applicable NCI CIO gene therapy treatment protocol. Age \>= 18 years. Note: Children are generally excluded from CIO gene therapy studies and inclusion on this follow-up study will be limited to 18 years and older. EXCLUSION CRITERIA: -Children